Abstract In chronic kidney disease (CKD), once injury from any number of disease processes reaches a threshold, there follows an apparently irreversible course toward decline in kidney function. The tubulointerstitium may play a key role in this common progression pathway. Direct injury, high metabolic demands, or stimuli from various other forms of renal dysfunction activate tubular cells. These, in turn, interact with interstitial tissue elements and inflammatory cells, causing further pathologic changes in the renal parenchyma. The tissue response to these changes thus generates a feed-forward loop of kidney injury and progressive loss of function. This article reviews the mechanisms of this negative cycle mediating CKD.
Introduction
The tubulointerstitium includes the tubules, which comprise about 80% of the kidney volume, and the compartment of the kidney bounded by the vasculature and nephrons. This component of the kidney performs critical functions (Table 1) , including the selective reabsorption and excretion of filtered molecules and the production and release of hormones. As such, the tubulointerstitium has a high energy demand and is susceptible to injury in situations of relative nutrient deprivation. It is involved in a multitude of disease processes, including obstructive uropathy, reflux nephropathy, pyelonephritis, metabolic disorders, hereditary diseases, and toxin exposures. Given the importance of the tubulointerstitium and its sensitivity to injury, it is not surprising that many of its physiological functions, when exaggerated, account for clinical manifestations of chronic kidney disease (CKD).
The contribution of deranged tubulointerstitial function to these manifestations raises a question as to the possible involvement of this compartment in the pathophysiology of progressive loss of kidney tissue as well. In CKD, once kidney damage reaches a threshold, the subsequent progression appears to be largely irreversible and independent of the initial kidney injury. It is theorized that the myriad primary kidney injuries that lead to end-stage kidney disease (ESKD) converge into one or more final common pathway(s) of disease progression. Tubulointerstitial injury and the cascade of events that it elicits may be one of these pathways.
The purpose of this educational review is to consider the mechanisms of progression that have been proposed to involve the tubulointerstitium. We emphasize that a purely negative physiological process is unlikely to exist, since biology has evolved to preserve and improve function. Therefore, in other circumstances the involved mechanisms are beneficial. For example, macrophages may help repair lesions by recruiting cellular elements and producing a provisional extracellular matrix (ECM), but these same actions may mediate inflammation or produce fibrogenic cytokines. This concept of misdirected repair has been considered in a previous issue of Pediatric Nephrology [1] .
Model theories of CKD progression
Two models have been proposed for how kidney injury leads to ESKD, with emphasis on the involvement of the glomeruli and the tubulointerstitium, respectively [2] . In the "overload hypothesis," an initial kidney injury results in a decrease in the number of functioning nephrons. In response, the remaining nephrons manifest compensatory increases in function. This causes further nephron damage and loss, generating a feed-forward cycle that leads to ESKD. Alternatively, the "fibrosis hypothesis" suggests that a variety of initial kidney insults result in tubulointerstitial injury, eliciting further inflammation and damage to the tubulointerstitium that proceeds to ESKD. These pathways are not mutually exclusive, but represent two ways of conceptualizing the progressive nature of CKD.
The scientific literature has implicated the tubulointerstitium in progressive kidney loss for several decades. In 1970, Schainuck and colleagues defined a pathologic correlate for declining glomerular filtration rate (GFR) in patients with various glomerulopathies [3] . These researchers found that GFR was inversely related to the severity of interstitial damage seen in biopsy samples. In contrast, a relationship between GFR and histologic severity of glomerular injury was not found. Further studies showed that increased interstitial volume and fibrosis, a decrease in peritubular capillaries, morphologic changes in tubular epithelial cells, and intensity of interstitial inflammation all correlate with kidney function deterioration [4] .
This relationship between tubulointerstitial injury and deteriorating kidney function could have been influenced by both sampling bias and the pattern of glomerular damage [5] . Glomerular histology may be more subject to sample bias in diseases with focal been associated with progressive kidney disease [8] . Thus, although "severity" of proteinuria usually has been characterized by the amount of protein present, it is likely that a specific characteristic of the proteinuria-such as the nature of the molecules that are present in the filtrate-is essential for it to cause tubulointerstitial damage. Conversely, it is worth noting that, if tubular reabsorptive mechanisms are disturbed, increased urine protein could represent a result, rather than a cause, of tubular damage in progressive CKD.
Activation of tubular cells: a central event in progressive tubulointerstitial disease
Assuming that in many cases proteinuria does cause tubulointerstitial injury, several mechanisms might be implicated based on events observed in acute processes [8, 9] . Protein casts may obstruct the tubular lumen. Tubular cells may be damaged as protein reabsorption is increased in response to filtered load, possibly through overloading and rupture of lysosomes or by an overwhelming energy demand on the tubular cells. However, these mechanisms have not been proven by experimental evidence. Non-protein substances in the urine could be toxic to the cells. Ultimately, the biologically active molecules present in the proteinuric filtrate induce changes in tubular cells from being highly differentiated to a less differentiated state wherein they mediate a variety of pathogenic processes. Thus, instead of serving as a polarized barrier that regulates the transport of molecules into and out of the glomerular filtrate, the activated epithelium releases cytokines, recruits inflammatory cells and fibroblasts, and serves as a source of stimuli of other cellular events that contribute to CKD (Fig. 2) .
Response to filtered load of plasma molecules The roles of different filtered molecules in the pathogenesis of progression are uncertain. In the normal state, the three proteins megalin, cubilin, and amnionless form a receptor complex that efficiently binds and reabsorbs filtered albumin and other proteins in the proximal tubule [10] . Megalin is a large transmembrane protein and a member of the lowdensity lipoprotein receptor family; its intracellular tail includes phosphorylation, signaling, and protein interaction motifs that may enable it to initiate intracellular signaling cascades [11] . Cubilin colocalizes with megalin on the proximal tubule membrane and is required for albumin binding, whereas megalin is important for internalization of albumin into the cell [12] . Amnionless facilitates the transport of cubilin to the proximal tubule membrane and assists in ligand endocytosis [10] . When tubular protein delivery increases, such as in glomerular damage, the capacity of the receptor complex is likely overwhelmed, resulting in the increased delivery of proteins and other toxins to the more distal tubule [10] .
Albumin stimulates tubular cell nuclear factor kappa-B (NF-κB) and signal transducer and activator of transcription (STAT), which in turn upregulate chemokines, including macrophage chemotactic factor 1 (MCP-1) and regulated upon activation, normal T cell expressed, and secreted (RANTES), and lead to inflammatory infiltration and eventual tubular injury [5] . 
Physiological maintenance of the progression cycle
Abnormal glomerular filtration, inflammation, fibrogenesis, and hypoxia, all common pathophysiological consequences of various kidney diseases, contribute to tubulointerstitial injury and activation as described thus far. In turn, tubulointerstitial injury perpetuates a pathway of further kidney injury, likely contributing to the progression of CKD (Fig. 4) .
Tubulointerstitial injury causes the accumulation of inflammatory cells in the interstitium. Cytokines such as TGF-β inhibit afferent arteriolar vasoconstriction. Extracellular matrix proteins are altered, and there is a decrease in the response of vascular smooth muscle cells to contractile stimuli. Conversely, the activation of hypertensive mechanisms stimulates vasoconstriction and decreased perfusion of the tubulointerstitium [45]. In addition, tubulointerstitial injury itself increases hypoxia and furthers kidney damage. The increased inflammatory cell proliferation and downstream fibrosis that occur in the interstitium increases the distance between tubules and the capillaries that supply oxygen [5] . Moreover, the diffusion of oxygen through the interstitium is limited by inflammation. Tubulointerstitial fibrosis also has been correlated with a loss of peritubular capillaries [5, 34] . A perpetuating pattern of kidney injury is established, whereby hypoxia leads to tubulointerstitial injury and inflammation, which in turn worsens renal hypoxia.
Finally, tubular damage leads to tubular dropout and resultant atubular glomeruli, decreasing the number of functional nephrons. There is a compensatory increase in remnant single-nephron blood flow in response. The remaining nephrons hypertrophy, adapt to increased filtration pressure, and become more vulnerable to disease and pathologic changes. Tubular atrophy also increases fluid delivery to the macula densa and triggers a reduction in GFR via tubuloglomerular feedback. Subsequently, there is exacerbation of glomerulosclerosis, leading to further filtrate leak and proteinuria, again perpetuating tubulointerstitial damage. Eventually, the capacity of the system to respond by autoregulating glomerular blood flow is lost, exacerbating hypoxia/ischemia and decreasing the number of remaining functional nephrons.
Together, these events create a cycle of injury, cell activation, and misdirected repair that is common to a wide variety of causes of CKD. Further study of these biological responses will enable us to better elucidate the mechanisms of tubulointerstitial damage and determine possible pathways for therapeutic intervention.
